FDA Orange Book · active-ingredient family
Pitavastatin magnesium
Pitavastatin magnesium is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:ZYPITAMAG · NDA 208379
1
Brand (NDA)
0
Generics (ANDA)
1
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ZYPITAMAGRLD×3 | MEDICURE | NDA 208379 | — | Jul 14, 2017 |
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8829186 | Jan 19, 2031 | in 4 yr 8 mo | SubstanceProduct |
Pitavastatin magnesium — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
